MedPath

Comparison of the effect and side effects of two way of progesterone suppository use in IVF cycles

Phase 2
Conditions
artificial fertilization.
Complication associated with artificial fertilization, unspecified
Registration Number
IRCT138807192568N1
Lead Sponsor
Valiasre reaserch center, Tehran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
150
Inclusion Criteria

Inclusion criteria are : 20-37 years old wemon candidate for first ICSI cycle
Exclusion criteria : FSH>8ng/ml ,Hypotyroidy,hyperprolactinemia

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biochemical pregnancy. Timepoint: 2 weeks after drug administration. Method of measurement: blood sample - BHCG.
Secondary Outcome Measures
NameTimeMethod
Perineal itching due to Cyclogest use in vaginal or rectal form. Timepoint: 2 weeks after start of drug. Method of measurement: Ask of patients.;Vaginal discharge due to cyclogest use in vaginal and rectal form. Timepoint: 2 weeks after drug administration. Method of measurement: Ask of pationts.
© Copyright 2025. All Rights Reserved by MedPath